EBS — Emergent BioSolutions Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for Emergent BioSolutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	576	643	112	99.5	205
Net Total Accounts Receivable
Net Total Receivables	275	159	191	155	84.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,272	1,210	680	599	663
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	828	837	399	282	216
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	2,959	3,166	1,823	1,390	1,319
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	374	1,229	651	162	132
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,340	1,779	1,174	907	796
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,619	1,388	649	483	523
Total Liabilities & Shareholders' Equity	2,959	3,166	1,823	1,390	1,319
Total Common Shares Outstanding